During the past decade, Kliniken der Stadt Köln gGmbH Krankenhaus Holweide; Brustzentrum conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kliniken der Stadt Köln gGmbH Krankenhaus Holweide; Brustzentrum" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "Genomic Health®, Inc." with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Kliniken der Stadt Köln gGmbH Krankenhaus Holweide; Brustzentrum" are "Breast Cancer" (1 trials), "Breast Cancer Female" (1 trials), "Breast Neoplasms" (1 trials), "Carcinoma, Ductal, Breast" (1 trials) and "Triple Negative Breast Neoplasms" (1 trials). Many other conditions were trialed in "Kliniken der Stadt Köln gGmbH Krankenhaus Holweide; Brustzentrum" in a lesser frequency.

Most popular intervention types in "Kliniken der Stadt Köln gGmbH Krankenhaus Holweide; Brustzentrum" are "Drug" (5 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "trastuzumab" (2 trials), "Abemaciclib 50 MG; 150mg 1-0-1 per os" (1 trials), "Atezolizumab" (1 trials), "Biopsy before and after three weeks of study treatment" (1 trials) and "Capecitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kliniken der Stadt Köln gGmbH Krankenhaus Holweide; Brustzentrum" are 3 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Kliniken der Stadt Köln gGmbH Krankenhaus Holweide; Brustzentrum". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Kliniken der Stadt Köln gGmbH Krankenhaus Holweide; Brustzentrum, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kliniken der Stadt Köln gGmbH Krankenhaus Holweide; Brustzentrum, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".